Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Pettinella
Observed names:
F. Pettinella,
Pettinella, F
Institution:
University of Verona
Observed institutions:
University of Verona,
Yale University
ORCID:
0000-0002-7940-589X
Observed ORCID:
0000-0002-7940-589X
OpenAlex ID:
A5045777866
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress
2022
·
Elisa Montaldo
, Eleonora Lusito
, et al.
·
Nature Immunology
·
229
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
2018
·
Charles Li
, Elena Bonazzoli
, et al.
·
Proceedings of the National Academy of Sciences
·
94
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro
2016
·
Stefania Bellone
, Eliana Bignotti
, et al.
·
Gynecologic Oncology
·
91
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy
2019
·
Luca Zammataro
, Salvatore Lopez
, et al.
·
Proceedings of the National Academy of Sciences
·
88
A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
2018
·
Chanhee Han
, Stefania Bellone
, et al.
·
Gynecologic Oncology
·
77
PDF
SYD985, a Novel Duocarmycin-Based HER2-Targeting Antibody–Drug Conjugate, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/Neu Expression
2017
·
Gulden Menderes
, Elena Bonazzoli
, et al.
·
Clinical Cancer Research
·
73
SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression
2017
·
Gulden Menderes
, Elena Bonazzoli
, et al.
·
Gynecologic Oncology
·
56
Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors
2024
·
Francesca Pettinella
, Barbara Mariotti
, et al.
·
Cell Reports Medicine
·
50
In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers
2018
·
Gary Altwerger
, Elena Bonazzoli
, et al.
·
Molecular Cancer Therapeutics
·
39
Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer
2018
·
Elena Bonazzoli
, Federica Predolini
, et al.
·
Clinical Cancer Research
·
31
Superior in vitro and in vivo activity of trastuzumab-emtansine (T-DM1) in comparison to trastuzumab, pertuzumab and their combination in epithelial ovarian carcinoma with high HER2/neu expression
2017
·
Gulden Menderes
, Elena Bonazzoli
, et al.
·
Gynecologic Oncology
·
24
Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo
2017
·
Gulden Menderes
, Elena Bonazzoli
, et al.
·
Medical Oncology
·
22
Uncovering common transcriptional features shared by mature peripheral blood PMN-MDSCs and tumor-infiltrating neutrophils in humans
2025
·
Chiara Lattanzi
, Francisco Bianchetto-Aguilera
, et al.
·
OncoImmunology
·
17
Effects of Magnetic Nanoparticles on the Functional Activity of Human Monocytes and Dendritic Cells
2023
·
Marta Donini
, Francesca Pettinella
, et al.
·
International Journal of Molecular Sciences
·
16
PDF
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis
2022
·
Sara Costa
, Dalila Bevilacqua
, et al.
·
Frontiers in Immunology
·
13
PDF
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients
2023
·
Annalisa Adamo
, Cristina Frusteri
, et al.
·
OncoImmunology
·
12
PDF
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients
2023
·
Francesca Pettinella
, Chiara Lattanzi
, et al.
·
Cancers
·
7
PDF
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
2019
·
Li, C
, Bonazzoli, E
, et al.
·
Proceedings of the National Academy of Sciences
·
3
SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/neu expression.
2017
·
Gulden Menderes
, Elena Bonazzoli
, et al.
·
Journal of Clinical Oncology
·
3
Remarkable in vitro and in vivo activity of IMGN853, an antibody-drug conjugate targeting folate receptor alpha linked to the tubulin-disrupting maytansinoid DM4, in biologically aggressive (type II) endometrial cancers
2018
·
G. Altwerger
, E. Bonazzoli
, et al.
·
Gynecologic Oncology
·
2
Abstract 47: SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/neu expression
2017
·
Gulden Menderes
, Elena Bonazzoli
, et al.
·
Cancer Research
·
2
Neratinib shows efficacy in the treatment of HER2/neu amplified epithelial ovarian carcinoma in vitro and in vivo
2017
·
G. Menderes
, E. Bonazzoli
, et al.
·
Gynecologic Oncology
·
1
Data from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers
2023
·
Gary Altwerger
, Elena Bonazzoli
, et al.
Supplementary Table 2 from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers
2023
·
Gary Altwerger
, Elena Bonazzoli
, et al.
Supplementary Figure 1 from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers
2023
·
Gary Altwerger
, Elena Bonazzoli
, et al.
Show more works
View as search
Works count:
44
Citation count:
950
H-index:
14
I10-index:
16
Year
Topic
Type